Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Summary table of answers to the multiresponse question “what would make participation easier for you or others?”, stratified per diagnostic group

From: Experiences of and recommendations on clinical trial design in Alzheimer’s disease from the participant’s point of view: a mixed-methods study in two clinical trial centers in the Netherlands

What would make participation easier for you or others?

Overall

Alzheimer’s disease

Mild Cognitive impairment

Cognitively normal

N

% (ntotal=71)

n

% (nAD=33)

n

% (nMCI=19)

n

% (nCN=19)

Less chance to receive placebo

38

53.5%

18

54.5%

13

68.4%

7

36.8%

Shorter travel time

27

38.0%

14

42.4%

6

31.6%

7

36.8%

Less frequent lumbar puncture

22

31.0%

12

36.4%

4

21.1%

6

31.6%

Home visits

12

16.9%

9

27.3%

2

10.5%

1

5.3%

Less frequent visits to center

6

8.5%

5

15.2%

1

5.3%

0

0.0%

Study partner burden

9

12.7%

4

12.1%

1

5.3%

4

21.1%

Less frequent MRI scan

8

11.3%

3

9.1%

1

5.3%

4

21.1%

Less frequent PET scan

6

8.5%

3

9.1%

1

5.3%

2

10.5%

More compensation

5

7.0%

1

3.0%

4

21.1%

0

0%

Less frequent memory assessments

4

5.6%

2

6.1%

1

5.3%

1

5.3%

Less frequent depression assessments

2

2.8%

0

0%

2

10.5%

0

0%